Evidence map›Paper›PMID 26962050›Full record

ArticleOpen biology2016

Genomic islands 1 and 2 play key roles in the evolution of extensively drug-resistant ST235 isolates of Pseudomonas aeruginosa.

Piklu Roy Chowdhury, Martin Scott, Paul Worden, Peter Huntington, Bernard Hudson, Thomas Karagiannis, Ian G Charles, Steven P Djordjevic

Open access · goldAbstract read
In one paragraph

Article in Open biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. ThemBio · 2026
    Article
  5. Article
  6. Multiple regional outbreaks caused by global and local VIM-producing Klebsiella pneumoniae clones in Poland, 2006-2019.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  7. High-riskHeliyon · 2025
    Article
  8. Global genomic epidemiology ofMicrobial genomics · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Worldwide Dissemination ofAntibiotics (Basel, Switzerland) · 2023
    Review
  13. Article
  14. Article
  15. Novel Molecular Markers Linked toAntibiotics (Basel, Switzerland) · 2021
    Article
  16. Mobile Carbapenemase Genes inFrontiers in microbiology · 2021
    Review
  17. Article
  18. TnMicroorganisms · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Piklu Roy ChowdhuryThe ithree institute, Faculty of Science, University of Technology, Sydney, PO Box 123, Broadway, New South Wales 2007, Australia Department of Primary Industries, Elizabeth Macarthur Agriculture Institute, PMB 4008, Camden, New South Wales 2567, Australia piklu.bhattacharya@uts.edu.au.ORCID http://orcid.org/0000-0003-4352-603X
Martin ScottThe ithree institute, Faculty of Science, University of Technology, Sydney, PO Box 123, Broadway, New South Wales 2007, Australia.
Paul WordenThe ithree institute, Faculty of Science, University of Technology, Sydney, PO Box 123, Broadway, New South Wales 2007, Australia.
Peter HuntingtonPathology North, The Royal North Shore Hospital, St Leonards, New South Wales 2065, Australia.
Bernard HudsonPathology North, The Royal North Shore Hospital, St Leonards, New South Wales 2065, Australia.
Thomas KaragiannisSEALS Department of Microbiology, Level 4, Campus Centre Prince of Wales Hospital, Baker Street, Randwick, New South Wales 2031, Australia.
Ian G CharlesThe ithree institute, Faculty of Science, University of Technology, Sydney, PO Box 123, Broadway, New South Wales 2007, Australia.
Steven P DjordjevicThe ithree institute, Faculty of Science, University of Technology, Sydney, PO Box 123, Broadway, New South Wales 2007, Australia steven.djordjevic@uts.edu.au.
University of Technology Sydney · AURoyal North Shore Hospital · AUPrince of Wales Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomonas aeruginosa are noscomially acquired, opportunistic pathogens that pose a major threat to the health of burns patients and the immunocompromised. We sequenced the genomes of P. aeruginosa isolates RNS_PA1, RNS_PA46 and RNS_PAE05, which displayed resistance to almost all frontline antibiotics, including gentamicin, piperacillin, timentin, meropenem, ceftazidime and colistin. We provide evidence that the isolates are representatives of P. aeruginosa sequence type (ST) 235 and carry Tn6162 and Tn6163 in genomic islands 1 (GI1) and 2 (GI2), respectively. GI1 disrupts the endA gene at precisely the same chromosomal location as in P. aeruginosa strain VR-143/97, of unknown ST, creating an identical CA direct repeat. The class 1 integron associated with Tn6163 in GI2 carries a blaGES-5-aacA4-gcuE15-aphA15 cassette array conferring resistance to carbapenems and aminoglycosides. GI2 is flanked by a 12 nt direct repeat motif, abuts a tRNA-gly gene, and encodes proteins with putative roles in integration, conjugative transfer as well as integrative conjugative element-specific proteins. This suggests that GI2 may have evolved from a novel integrative conjugative element. Our data provide further support to the hypothesis that genomic islands play an important role in de novo evolution of multiple antibiotic resistance phenotypes in P. aeruginosa.

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsEvolution, MolecularGenome, BacterialGenomic IslandsHumansPhylogenyPseudomonas aeruginosaPseudomonas InfectionsAnti-Bacterial Agentsclass 1 integrongenomic islandmultiple drug resistancePseudomonas aeruginosaβ-lactamases

Identifiers

PMID26962050
PMCPMC4821235
OpenAlexW2296431598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.